BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30072848)

  • 21. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.
    Deharo JC; Quatre A; Mancini J; Khairy P; Le Dolley Y; Casalta JP; Peyrouse E; Prévôt S; Thuny F; Collart F; Raoult D; Habib G; Franceschi F
    Heart; 2012 May; 98(9):724-31. PubMed ID: 22523057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of leukocytosis after cardiac device implantation.
    Tompkins C; Cheng A; Brinker JA; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    Am J Cardiol; 2013 Jun; 111(11):1608-12. PubMed ID: 23523060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.
    Sohail MR; Hussain S; Le KY; Dib C; Lohse CM; Friedman PA; Hayes DL; Uslan DZ; Wilson WR; Steckelberg JM; Baddour LM;
    J Interv Card Electrophysiol; 2011 Aug; 31(2):171-83. PubMed ID: 21365264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.
    Krishnamoorthy A; Pokorney SD; Lewis RK; Daubert JP; Greenfield RA; Hegland DD; Milano CA; Rogers JG; Schroder JN; Patel CB; Piccini JP
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1199-205. PubMed ID: 24890850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients.
    El-Chami MF; Jacobsen CM; Griffiths RI; Hansen LK; Wold N; Amorosi SL; Stivland TM; Knight BP; Weiss R; Mark GE; Biffi M; Probst V; Lambiase PD; Miller MA; Baddour LM
    Heart Rhythm; 2021 Aug; 18(8):1301-1309. PubMed ID: 33887452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis.
    Chew D; Somayaji R; Conly J; Exner D; Rennert-May E
    BMJ Open; 2019 Sep; 9(9):e029537. PubMed ID: 31481556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.
    Koneru JN; Jones PW; Hammill EF; Wold N; Ellenbogen KA
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections of implantable cardiac rhythm devices: predisposing factors and outcome.
    Ipek EG; Guray U; Demirkan B; Guray Y; Aksu T
    Acta Cardiol; 2012 Jun; 67(3):303-10. PubMed ID: 22870738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
    Rennert-May E; Chew D; Lu S; Chu A; Kuriachan V; Somayaji R
    Heart Rhythm; 2020 Jul; 17(7):1125-1131. PubMed ID: 32087358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac implantable electronic device implantation and device-related infection.
    Modi V; Shah K; Ferraro B; Gasimli-Gamache L; Nanda S; Stevens S; Shirani J
    Europace; 2023 Aug; 25(9):. PubMed ID: 37572046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device-Related Infections: Analysis of 13 Years of Inpatient Data in the United States.
    Hosseini SM; Rozen G; Kaadan MI; Galvin J; Ruskin JN
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1450-1458. PubMed ID: 31857046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious complications in patients with cardiac implantable electronic devices: risk factors, prevention, and prognosis.
    Polewczyk A; Jacheć W; Polewczyk AM; Tomasik A; Janion M; Kutarski A
    Pol Arch Intern Med; 2017 Sep; 127(9):597-607. PubMed ID: 28724879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection.
    Pichlmaier M; Knigina L; Kutschka I; Bara C; Oswald H; Klein G; Bisdas T; Haverich A
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1482-90. PubMed ID: 21570093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infections of cardiac implantable electronic devices: Epidemiology, classification, treatment, and prognosis.
    Sławiński G; Lewicka E; Kempa M; Budrejko S; Raczak G
    Adv Clin Exp Med; 2019 Feb; 28(2):263-270. PubMed ID: 30048058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial.
    Mittal S; Wilkoff BL; Poole JE; Kennergren C; Wright DJ; Berman BJ; Riggio D; Sholevar DP; Martinez-Arraras J; Moubarak JB; Schaller RD; Love JC; Pickett RA; Philippon F; Eldadah Z; Lande JD; Lexcen DR; Holbrook R; Tarakji KG
    Heart Rhythm; 2021 Jul; 18(7):1142-1150. PubMed ID: 33781980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac implantable electronic device infection in patients with end-stage renal disease.
    Guha A; Maddox WR; Colombo R; Nahman NS; Kintziger KW; Waller JL; Diamond M; Murphy M; Kheda M; Litwin SE; Sorrentino RA
    Heart Rhythm; 2015 Dec; 12(12):2395-401. PubMed ID: 26253036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and time delay associated with cardiac device infections: Leiden device registry.
    Lekkerkerker JC; van Nieuwkoop C; Trines SA; van der Bom JG; Bernards A; van de Velde ET; Bootsma M; Zeppenfeld K; Jukema JW; Borleffs JW; Schalij MJ; van Erven L
    Heart; 2009 May; 95(9):715-20. PubMed ID: 19036758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.